6beta-Acetoxynortropane: a Potent Muscarinic Agonist with Apparent Selectivity Toward M2-receptors
Overview
Authors
Affiliations
A series of tropane derivatives, related in structure to baogongteng A (1), an alkaloid from a Chinese herb, were synthesized. 6beta-Acetoxynortropane (5) had weak affinity (Ki 22 microM) for central (M1) muscarinic receptors in a [3H]quinuclidinyl benzilate binding assay but had extremely high affinity (Ki 2.6 nM) and selectivity for M2-muscarinic receptors expressed in CHO cells. It had 13-fold lower affinity for M4-receptors, 260-fold lower affinity for M3-receptors, and 8200-fold lower affinity for M1-receptors expressed in CHO cells. The 6beta-carbomethoxy analogue (14) of baogongteng A had only weak affinity for M2-muscarinic receptors, as did 6beta-carbomethoxynortropane (13) and 6beta-acetoxytropane (4). In transfected CHO cells, 6beta-acetoxynortropane (5) was an agonist at M2-receptors, based on a GTP-elicited decrease in affinity, and a full agonist with an IC50 of 11 nM at M4-receptors, based on inhibition of cyclic AMP accumulation, while being a full agonist at M1-receptors with an EC50 of 23 nM and a partial agonist at M3-receptors with an EC50 of 3.6 nM, based in both cases on stimulation of phosphoinositide breakdown. All of the 16 tropane derivatives had weak affinities for central alpha4beta2-nicotinic receptors with 6beta-carbomethoxynortropane (13) having the highest affinity, which was still 150-fold less than that of nicotine. 6beta-Acetoxynortropane (5) represents a potent muscarinic agonist with apparent selectivity toward M2-receptors.
Multitargeting nature of muscarinic orthosteric agonists and antagonists.
Myslivecek J Front Physiol. 2022; 13:974160.
PMID: 36148314 PMC: 9486310. DOI: 10.3389/fphys.2022.974160.
Tamalunas A, Wendt A, Springer F, Ciotkowska A, Rutz B, Wang R Front Physiol. 2022; 13:884057.
PMID: 35677088 PMC: 9168773. DOI: 10.3389/fphys.2022.884057.
Huang R, Li B, Tamalunas A, Waidelich R, Stief C, Hennenberg M Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(4):471-485.
PMID: 35141760 PMC: 8873054. DOI: 10.1007/s00210-022-02218-2.
Li B, Huang R, Wang R, Liu Y, Stief C, Hennenberg M Pharmacol Res Perspect. 2021; 9(3):e00771.
PMID: 33929093 PMC: 8085950. DOI: 10.1002/prp2.771.
Knol R, van den Bos J, Janssen A, de Bruin K, van Eck-Smit B, Booij J Int J Mol Imaging. 2011; 2011:709416.
PMID: 21755053 PMC: 3132655. DOI: 10.1155/2011/709416.